Developer docs
API playgroundTry for free, no card

Search company profiles

Małopolska Centre of Biotechnology UJ

Full company profile

uuid004v4t4

Namestring
Małopolska Centre of Biotechnology UJ
Legal namestring
Małopolskie Centrum Biotechnologii - Uniwersytet Jagielloński
Websiteurl
mcb.uj.edu.pl
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Małopolska Centre of Biotechnology UJ (MCB) is a multidisciplinary biotechnology research center operating as a unit of Jagiellonian University (Uniwersytet Jagielloński), Poland's oldest university founded in 1364, located at ul. Gronostajowa 7A in Kraków. Established in 2010 and operationally launched in 2014 with a Max Planck Society joint laboratory, MCB hosts 19 active research groups spanning structural biology, proteomics, virology, bioinformatics, computational genomics, microbial genomics, chromatin biology, photobiology, plant molecular biology, and nanomedicine. The center operates 10 core facilities — including cryo-EM infrastructure, protein crystallography, genomics, proteomics and mass spectrometry, cell banking, confocal microscopy, flow cytometry, biomolecular interaction analysis, and an animal facility — that are shared across research groups and partner institutions.

MCB serves scientific end-users through doctoral training (11 PhD positions per cohort via the Doctoral School of Exact and Natural Sciences), competitive research output (notable 2026 publications in Nature Communications on a global urban RNA virus atlas and in Nucleic Acids Research on ruthenium/osmium chromatin recognition with EPFL), and large-scale international collaborations via the MetaSUB Consortium and Horizon Europe Twinning programs. Major current initiatives include the IMPACT-Cell Twinning project (€1.49M, 2026–2029) with EMBL and three other European partners, the TwinMed digital twin technologies project, and the POL-INSTRUCT drug discovery platform, both placed on the Polish Roadmap for Research Infrastructures in 2026.

The center has no commercial pricing or product revenue; it operates entirely on competitive public grant funding from Polish agencies (NCN, NAWA, Ministry of Science), the European Commission (Horizon Europe, Dioscuri Programme co-managed with Max Planck Society), and institutional support from Jagiellonian University. GTM motion is community-led — recruiting PhD students, attracting independent research group leaders through Dioscuri and TOP200 NAWA, and partnering with leading European research institutions for knowledge transfer.

Short descriptiontext

Małopolska Centre of Biotechnology UJ is a non-profit biotechnology research center within Jagiellonian University in Kraków, operating 19 research groups and 10 core facilities (cryo-EM, proteomics, genomics) funded entirely through public grants from Polish and European sources, with doctoral training and international Twinning collaborations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKraków, Poland
HQ citystring
Kraków
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotechnology research, structural biology, proteomics services, genomics research, academic research institutions
Industry5 codes
PRIMARYEDAHAGAI
Biomedical Sciences & Medical Research Institutes (University-Based)
Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Academic Biotechnology Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Research Grants
TypeManaged Services
Description

Funded primarily through competitive national grants from Narodowe Centrum Nauki (NCN), European Commission Horizon Europe programs, and international funding bodies including NAWA, with specific projects like OPUS, SONATA, and Twinning providing dedicated research financing

mcb.uj.edu.pl
2Twinning Project Funding
TypeManaged Services
Description

European Commission Twinning grant of 1,493,592.73 euro for IMPACT-Cell project on proteomics and structural biology, providing 36 months of funding starting Q4 2026

mcb.uj.edu.pl
3NAWA TOP200 Programme
TypeManaged Services
Description

Polish National Agency for Academic Exchange funding for researcher mobility under European Commission's Choose Europe for Science initiative, securing 2,377,600 PLN for Dr. Schacherl's independent research group

mcb.uj.edu.pl
4Dioscuri Programme
TypeManaged Services
Description

Funding of 300,000 euro per year for 5 years (extendable) for establishing Dioscuri Centres, with budget including leader salary up to 100,000 euro annually and research team costs

mcb.uj.edu.pl
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Dioscuri Centre
Description

A research excellence center established under the Dioscuri Programme, a joint initiative of Max Planck Society and National Science Centre, focused on interdisciplinary scientific excellence in Central and Eastern Europe. Currently led by Dr. Mateusz Sikora.

mcb.uj.edu.pl
Core offering1 text field

MCB UJ is a multidisciplinary academic research center conducting biotechnology research across 19 research groups and operating 10 core facilities (cell banking, genomics, structural biology, proteomics, animal facility, confocal microscopy, flow cytometry, biomolecular interaction, media lab, virology/BSL3). It provides doctoral training in biomedical sciences, secures competitive research grants, and delivers scientific collaboration services for academia and industry partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Identified nearly 55,000 RNA viruses with 77% previously unknown to science
+3 more records
Product overview1 text field

Małopolskie Centrum Biotechnologii (MCB) UJ is a research institution at Jagiellonian University in Kraków, Poland. It operates as a multi-laboratory research center with 20+ research groups across various biotechnology disciplines including molecular biology, virology, structural biology, bioinformatics, genomics, proteomics, and cell biology. The center provides research infrastructure through its Core Facilities (Cell Bank, Genomics Core Facility, Structural Biology Core Facility, Proteomics Core Facility, Animal Facility, Confocal Microscopy, Flow Cytometry, and Biomolecular Interaction & Stability facilities), and offers educational programmes including doctoral training. Major research initiatives include the Horizon Europe IMPACT-Cell Twinning project, TwinMed digital twin technologies project, and POL-INSTRUCT drug discovery platform.

Product and service10 records
1Cell Bank (Bank komórek)
CategoryCore Facility / Research Infrastructure
Description

Core facility providing cell banking services for research purposes. Cell repository used by internal research groups and external academic collaborators.

2Genomics Core Facility (Centrum Genomiki)
CategoryCore Facility / Research Infrastructure
Description

Core facility providing genomics services including sequencing and genomic analysis for research groups and external collaborators.

3Structural Biology Core Facility
CategoryCore Facility / Research Infrastructure
Description

Core facility providing structural biology services and equipment for protein and molecular structure analysis, including cryo-EM and protein crystallography.

4Proteomics Core Facility (Pracownia Analiz Proteomicznych)
CategoryCore Facility / Research Infrastructure
Description

Core facility providing proteomics and mass spectrometry services for protein analysis, supporting the IMPACT-Cell project.

5Animal Facility (Zwierzętarnia)
CategoryCore Facility / Research Infrastructure
Description

Core facility for animal research and experimentation supporting biomedical research projects.

6Laser Scanning Confocal Microscope
CategoryCore Facility / Research Infrastructure
Description

Advanced imaging facility providing laser scanning confocal microscopy capabilities for cellular and molecular imaging research.

7Flow Cytometry Core (Pracownia Cytometrii Przepływowej)
CategoryCore Facility / Research Infrastructure
Description

Core facility providing flow cytometry services for cell analysis and sorting, supporting immunology and cell biology research.

8Biomolecular Interaction & Stability Core Facility
CategoryCore Facility / Research Infrastructure
Description

Laboratory for characterizing biomolecular interactions and stability, supporting structural biology and drug discovery research.

9Media Lab
CategoryCore Facility / Research Infrastructure
Description

Laboratory facility for media preparation and related services supporting cell biology and microbiology research.

10Doctoral Programme in Biomedical Sciences
CategoryEducational Service
Description

PhD programme at the Doctoral School of Exact and Natural Sciences offering 11 positions for research at MCB in biomedical sciences.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
1ACK Cyfronet AGH
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-08-17
Description

Academic Computer Centre Cyfronet at AGH University of Science and Technology collaborating with MCB and Jagiellonian University on the TwinMed project for digital twin technologies in biomedicine.

mcb.uj.edu.pl
2Wrocław Centre for Networking and Supercomputing (WCSS)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-08-17
Description

Supercomputing centre at Wrocław University of Science and Technology partnering in TwinMed project, contributing high-performance computing infrastructure for biomedical applications and digital twin development.

mcb.uj.edu.pl
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-08-17
Description

Research centre Sano collaborating on TwinMed project for digital twin technologies in biomedicine and personalized medicine, complementing other AI-driven research initiatives in Poland.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-08-17
Description

Leading Polish research institute leading the POL-INSTRUCT project for interdisciplinary platform supporting drug discovery, with MCB's Prof. Przemysław Grudnik coordinating as key consortium partner.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-29
Description

Swiss Federal Institute of Technology collaborating with MCB researchers led by Prof. Curtis Davey on research into how ruthenium and osmium compounds recognize chromatin, involving Prof. Ursula Röthlisberger, Dr. Andrea Levy, and Prof. Paul Dyson.

6European Molecular Biology Laboratory (EMBL)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-28
Description

European Molecular Biology Laboratory from Germany is one of four leading European scientific institutions partnering with MCB in the IMPACT-Cell Twinning project, contributing to knowledge transfer in advanced proteomics, post-translational modifications analysis, single-cell research methods, and high-resolution structural biology.

mcb.uj.edu.pl
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-28
Description

Spanish healthcare research foundation participating as a partner institution in the IMPACT-Cell Twinning project, supporting transfer of knowledge and best practices in biomedical research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-28
Description

Danish university participating as a partner in the IMPACT-Cell Twinning project, contributing expertise to the collaboration on proteomics and structural biology research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-28
Description

Swedish university as one of four European partner institutions in the IMPACT-Cell Twinning project, providing knowledge transfer and collaboration in cryo-electron tomography and computational modeling.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-28
Description

German research organization initiating the Dioscuri Programme, managed jointly with National Science Centre Poland, supporting establishment of scientific excellence centres in Central and Eastern Europe.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-07-27
Description

International consortium coordinating global City Sampling Day initiative, with MCB's Dr. Paweł Łabaj initiating Kraków's participation in 2020, enabling analysis of nearly 3,000 samples from 102 cities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Polish research institute specializing in bioorganic chemistry, molecular biology, and drug discovery. Direct partner in the POL-INSTRUCT project and serves as a coordinating institution for similar research themes.

TypeRegional player
Description

Brno-based Czech research consortium with life sciences and advanced materials research. Comparable as a Central European academic research center with similar structural biology and molecular medicine focus, plus EU funding model.

TypeBroad incumbent
Description

German research center focused on infectious disease, microbiology, and immunology. Comparable for its virology research (relevant to MCB's ViroGenetics lab) and operations as a publicly funded research infrastructure with core facility model.

TypeDirect peer
Description

Germany-based research institute focused on molecular cell biology, genetics, and biophysics. Comparable as a European academic research center with strong grant funding model and core facility infrastructure, plus active Max Planck-MCB partnership.

TypeBroad incumbent
Description

UK research council laboratory with world-leading programs in structural biology, molecular biology, and cell biology. Comparable for its core facility model and Nobel-caliber output in overlapping research areas like cryo-EM and protein structure.

TypeBroad incumbent
Description

US-based biomedical and genomic research center with strong programs in structural biology, chemical biology, and infectious disease. Comparable for its core facility model, large-scale grant funding, and integration of computational biology with wet-lab research.

TypeDirect peer
Description

Warsaw-based Polish biomedical research institute with similar focus on molecular and cell biology, structural biology, and bioinformatics. Most direct comparable as a Polish academic research center with international scope and grant-funded operating model.

8European Molecular Biology Laboratory (EMBL)
TypeBroad incumbent
Description

Intergovernmental research organization in structural biology, proteomics, and genomics. Direct partner in MCB's IMPACT-Cell Twinning project and operates in overlapping research areas at significantly larger scale.

TypeBroad incumbent
Description

UK-based genomic research institute with focus on large-scale genomics, cancer, and infectious disease. Comparable for its genomics core capabilities, viral surveillance work (similar to MCB's MetaSUB RNA virus atlas), and academic grant-funded model.

TypeDirect peer
Description

Polish research center focused on computational medicine and digital health. Direct partner in MCB's TwinMed project and operates a comparable international research centre model with grant funding from EU and national sources.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Małopolska Centre of Biotechnology UJ

Academic Biotechnology Research Servicesmcb.uj.edu.pl

Małopolska Centre of Biotechnology UJ is a non-profit biotechnology research center within Jagiellonian University in Kraków, operating 19 research groups and 10 core facilities (cryo-EM, proteomics, genomics) funded entirely through public grants from Polish and European sources, with doctoral training and international Twinning collaborations.

What Małopolska Centre of Biotechnology UJ does

Małopolska Centre of Biotechnology UJ (MCB) is a multidisciplinary biotechnology research center operating as a unit of Jagiellonian University (Uniwersytet Jagielloński), Poland's oldest university founded in 1364, located at ul. Gronostajowa 7A in Kraków. Established in 2010 and operationally launched in 2014 with a Max Planck Society joint laboratory, MCB hosts 19 active research groups spanning structural biology, proteomics, virology, bioinformatics, computational genomics, microbial genomics, chromatin biology, photobiology, plant molecular biology, and nanomedicine. The center operates 10 core facilities — including cryo-EM infrastructure, protein crystallography, genomics, proteomics and mass spectrometry, cell banking, confocal microscopy, flow cytometry, biomolecular interaction analysis, and an animal facility — that are shared across research groups and partner institutions.

MCB serves scientific end-users through doctoral training (11 PhD positions per cohort via the Doctoral School of Exact and Natural Sciences), competitive research output (notable 2026 publications in Nature Communications on a global urban RNA virus atlas and in Nucleic Acids Research on ruthenium/osmium chromatin recognition with EPFL), and large-scale international collaborations via the MetaSUB Consortium and Horizon Europe Twinning programs. Major current initiatives include the IMPACT-Cell Twinning project (€1.49M, 2026–2029) with EMBL and three other European partners, the TwinMed digital twin technologies project, and the POL-INSTRUCT drug discovery platform, both placed on the Polish Roadmap for Research Infrastructures in 2026.

The center has no commercial pricing or product revenue; it operates entirely on competitive public grant funding from Polish agencies (NCN, NAWA, Ministry of Science), the European Commission (Horizon Europe, Dioscuri Programme co-managed with Max Planck Society), and institutional support from Jagiellonian University. GTM motion is community-led — recruiting PhD students, attracting independent research group leaders through Dioscuri and TOP200 NAWA, and partnering with leading European research institutions for knowledge transfer.

Małopolska Centre of Biotechnology UJ firmographics

Firmographics
Name
Małopolska Centre of Biotechnology UJ
Legal name
Małopolskie Centrum Biotechnologii - Uniwersytet Jagielloński
Website
https://mcb.uj.edu.pl
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Małopolska Centre of Biotechnology UJ is a non-profit biotechnology research center within Jagiellonian University in Kraków, operating 19 research groups and 10 core facilities (cryo-EM, proteomics, genomics) funded entirely through public grants from Polish and European sources, with doctoral training and international Twinning collaborations.
Ownership category
akta.pro rank

Małopolska Centre of Biotechnology UJ industry classification

Industry
Product category
Academic Biotechnology Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYEDAHAGAI
Biomedical Sciences & Medical Research Institutes (University-Based)
Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Biotechnology research
  • Structural biology
  • Proteomics services
  • Genomics research
  • Academic research institutions

Where Małopolska Centre of Biotechnology UJ is headquartered

Location

Headquarters

HQ city
Kraków
HQ country
Poland
HQ region
Europe

Offices1 record

Markets served

Małopolska Centre of Biotechnology UJ business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

  1. Research Grants: Funded primarily through competitive national grants from Narodowe Centrum Nauki (NCN), European Commission Horizon Europe programs, and international funding bodies including NAWA, with specific projects like OPUS, SONATA, and Twinning providing dedicated research financing
  2. Twinning Project Funding: European Commission Twinning grant of 1,493,592.73 euro for IMPACT-Cell project on proteomics and structural biology, providing 36 months of funding starting Q4 2026
  3. NAWA TOP200 Programme: Polish National Agency for Academic Exchange funding for researcher mobility under European Commission's Choose Europe for Science initiative, securing 2,377,600 PLN for Dr. Schacherl's independent research group
  4. Dioscuri Programme: Funding of 300,000 euro per year for 5 years (extendable) for establishing Dioscuri Centres, with budget including leader salary up to 100,000 euro annually and research team costs

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Małopolska Centre of Biotechnology UJ product offering

Product offering

Core offering

MCB UJ is a multidisciplinary academic research center conducting biotechnology research across 19 research groups and operating 10 core facilities (cell banking, genomics, structural biology, proteomics, animal facility, confocal microscopy, flow cytometry, biomolecular interaction, media lab, virology/BSL3). It provides doctoral training in biomedical sciences, secures competitive research grants, and delivers scientific collaboration services for academia and industry partners.

Product overview

Małopolskie Centrum Biotechnologii (MCB) UJ is a research institution at Jagiellonian University in Kraków, Poland. It operates as a multi-laboratory research center with 20+ research groups across various biotechnology disciplines including molecular biology, virology, structural biology, bioinformatics, genomics, proteomics, and cell biology. The center provides research infrastructure through its Core Facilities (Cell Bank, Genomics Core Facility, Structural Biology Core Facility, Proteomics Core Facility, Animal Facility, Confocal Microscopy, Flow Cytometry, and Biomolecular Interaction & Stability facilities), and offers educational programmes including doctoral training. Major research initiatives include the Horizon Europe IMPACT-Cell Twinning project, TwinMed digital twin technologies project, and POL-INSTRUCT drug discovery platform.

Differentiator

Problem solved

Functional benefit

Brands

  • Dioscuri Centre: A research excellence center established under the Dioscuri Programme, a joint initiative of Max Planck Society and National Science Centre, focused on interdisciplinary scientific excellence in Central and Eastern Europe. Currently led by Dr. Mateusz Sikora.

Products and services

  • Cell Bank (Bank komórek) Core facility providing cell banking services for research purposes. Cell repository used by internal research groups and external academic collaborators.
  • Genomics Core Facility (Centrum Genomiki) Core facility providing genomics services including sequencing and genomic analysis for research groups and external collaborators.
  • Structural Biology Core Facility Core facility providing structural biology services and equipment for protein and molecular structure analysis, including cryo-EM and protein crystallography.
  • Proteomics Core Facility (Pracownia Analiz Proteomicznych) Core facility providing proteomics and mass spectrometry services for protein analysis, supporting the IMPACT-Cell project.
  • Animal Facility (Zwierzętarnia) Core facility for animal research and experimentation supporting biomedical research projects.
  • Laser Scanning Confocal Microscope Advanced imaging facility providing laser scanning confocal microscopy capabilities for cellular and molecular imaging research.
  • Flow Cytometry Core (Pracownia Cytometrii Przepływowej) Core facility providing flow cytometry services for cell analysis and sorting, supporting immunology and cell biology research.
  • Biomolecular Interaction & Stability Core Facility Laboratory for characterizing biomolecular interactions and stability, supporting structural biology and drug discovery research.
  • Media Lab Laboratory facility for media preparation and related services supporting cell biology and microbiology research.
  • Doctoral Programme in Biomedical Sciences PhD programme at the Doctoral School of Exact and Natural Sciences offering 11 positions for research at MCB in biomedical sciences.

Quantifiable outcome

  • Identified nearly 55,000 RNA viruses with 77% previously unknown to science
  • +3 more outcomes

Companies that use Małopolska Centre of Biotechnology UJ

Customer profile

Segments1 record

Ideal customer profiles4 records

Małopolska Centre of Biotechnology UJ technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Małopolska Centre of Biotechnology UJ partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered major and core.

  • ACK Cyfronet AGHmajorStrategic or Co-development Partner · 17 August 2026Academic Computer Centre Cyfronet at AGH University of Science and Technology collaborating with MCB and Jagiellonian University on the TwinMed project for digital twin technologies in biomedicine.
  • Wrocław Centre for Networking and Supercomputing (WCSS)majorStrategic or Co-development Partner · 17 August 2026Supercomputing centre at Wrocław University of Science and Technology partnering in TwinMed project, contributing high-performance computing infrastructure for biomedical applications and digital twin development.
  • SanomajorStrategic or Co-development Partner · 17 August 2026Research centre Sano collaborating on TwinMed project for digital twin technologies in biomedicine and personalized medicine, complementing other AI-driven research initiatives in Poland.
  • Institute of Bioorganic Chemistry, Polish Academy of Sciences (ICHB PAN)coreStrategic or Co-development Partner · 17 August 2026Leading Polish research institute leading the POL-INSTRUCT project for interdisciplinary platform supporting drug discovery, with MCB's Prof. Przemysław Grudnik coordinating as key consortium partner.
  • EPFL (École Polytechnique Fédérale de Lausanne)coreStrategic or Co-development Partner · 29 July 2026Swiss Federal Institute of Technology collaborating with MCB researchers led by Prof. Curtis Davey on research into how ruthenium and osmium compounds recognize chromatin, involving Prof. Ursula Röthlisberger, Dr. Andrea Levy, and Prof. Paul Dyson.
  • European Molecular Biology Laboratory (EMBL)coreStrategic or Co-development Partner · 28 July 2026European Molecular Biology Laboratory from Germany is one of four leading European scientific institutions partnering with MCB in the IMPACT-Cell Twinning project, contributing to knowledge transfer in advanced proteomics, post-translational modifications analysis, single-cell research methods, and high-resolution structural biology.
  • Fundación para la Formación e Investigación Sanitarias de la Región de MurciacoreStrategic or Co-development Partner · 28 July 2026Spanish healthcare research foundation participating as a partner institution in the IMPACT-Cell Twinning project, supporting transfer of knowledge and best practices in biomedical research.
  • Syddansk Universitet (University of Southern Denmark)coreStrategic or Co-development Partner · 28 July 2026Danish university participating as a partner in the IMPACT-Cell Twinning project, contributing expertise to the collaboration on proteomics and structural biology research.
  • Lunds Universitet (Lund University)coreStrategic or Co-development Partner · 28 July 2026Swedish university as one of four European partner institutions in the IMPACT-Cell Twinning project, providing knowledge transfer and collaboration in cryo-electron tomography and computational modeling.
  • Max Planck SocietycoreStrategic or Co-development Partner · 28 July 2026German research organization initiating the Dioscuri Programme, managed jointly with National Science Centre Poland, supporting establishment of scientific excellence centres in Central and Eastern Europe.
  • MetaSUB ConsortiummajorStrategic or Co-development Partner · 27 July 2026International consortium coordinating global City Sampling Day initiative, with MCB's Dr. Paweł Łabaj initiating Kraków's participation in 2020, enabling analysis of nearly 3,000 samples from 102 cities.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Małopolska Centre of Biotechnology UJ competitors and assessment

Company assessment

Direct peers

Regional players

  • CEITEC - Central European Institute of Technology: Brno-based Czech research consortium with life sciences and advanced materials research. Comparable as a Central European academic research center with similar structural biology and molecular medicine focus, plus EU funding model.

Broad incumbents

  • Helmholtz Centre for Infection Research (HZI): German research center focused on infectious disease, microbiology, and immunology. Comparable for its virology research (relevant to MCB's ViroGenetics lab) and operations as a publicly funded research infrastructure with core facility model.
  • MRC Laboratory of Molecular Biology (LMB): UK research council laboratory with world-leading programs in structural biology, molecular biology, and cell biology. Comparable for its core facility model and Nobel-caliber output in overlapping research areas like cryo-EM and protein structure.
  • Broad Institute of MIT and Harvard: US-based biomedical and genomic research center with strong programs in structural biology, chemical biology, and infectious disease. Comparable for its core facility model, large-scale grant funding, and integration of computational biology with wet-lab research.
  • European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in structural biology, proteomics, and genomics. Direct partner in MCB's IMPACT-Cell Twinning project and operates in overlapping research areas at significantly larger scale.
  • Wellcome Sanger Institute: UK-based genomic research institute with focus on large-scale genomics, cancer, and infectious disease. Comparable for its genomics core capabilities, viral surveillance work (similar to MCB's MetaSUB RNA virus atlas), and academic grant-funded model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Małopolska Centre of Biotechnology UJ social profiles

Digital presence

Małopolska Centre of Biotechnology UJ financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Małopolska Centre of Biotechnology UJ leadership team

Management profile

Number of profiles

Profiles17 records

Małopolska Centre of Biotechnology UJ funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Małopolska Centre of Biotechnology UJ M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Małopolska Centre of Biotechnology UJ

What does Małopolska Centre of Biotechnology UJ do?

MCB UJ is a multidisciplinary academic research center conducting biotechnology research across 19 research groups and operating 10 core facilities (cell banking, genomics, structural biology, proteomics, animal facility, confocal microscopy, flow cytometry, biomolecular interaction, media lab, virology/BSL3). It provides doctoral training in biomedical sciences, secures competitive research grants, and delivers scientific collaboration services for academia and industry partners.

Is Małopolska Centre of Biotechnology UJ a public or private company?

Małopolska Centre of Biotechnology UJ is a private company. It is classified as state government owned and is currently operating.

When was Małopolska Centre of Biotechnology UJ founded?

Małopolska Centre of Biotechnology UJ was founded in 2010. It employs 11 to 50 people.

Where is Małopolska Centre of Biotechnology UJ based?

Małopolska Centre of Biotechnology UJ is headquartered in Kraków, Poland, in the Europe region.

How does Małopolska Centre of Biotechnology UJ make money?

Four revenue lines are on record. Research Grants are the primary driver. The others are twinning Project Funding, NAWA TOP200 Programme and dioscuri Programme.

Who are Małopolska Centre of Biotechnology UJ's main competitors?

Direct peers on record are Institute of Bioorganic Chemistry, Polish Academy of Sciences (ICHB PAN), Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), International Institute of Molecular and Cell Biology (IIMCB) and Sano Centre for Computational Personalised Medicine. CEITEC - Central European Institute of Technology is listed as a regional player. Broad incumbents are Helmholtz Centre for Infection Research (HZI), MRC Laboratory of Molecular Biology (LMB), Broad Institute of MIT and Harvard, European Molecular Biology Laboratory (EMBL) and Wellcome Sanger Institute.

Does Małopolska Centre of Biotechnology UJ have an API?

No public API is recorded for Małopolska Centre of Biotechnology UJ.

What industry is Małopolska Centre of Biotechnology UJ in?

Małopolska Centre of Biotechnology UJ's product category is Academic Biotechnology Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales